Veeva Systems (VEEV) Shareholder Glynn Capital Management Trimmed Holding; Pfizer (PFE) Shareholder Wms Partners Has Increased Stake by $1.38 Million as Share Price Rose

Veeva Systems Inc. (NYSE:VEEV) Logo

Glynn Capital Management Llc decreased its stake in Veeva Systems Inc. (VEEV) by 19.88% based on its latest 2018Q3 regulatory filing with the SEC. Glynn Capital Management Llc sold 53,504 shares as the company’s stock declined 12.12% with the market. The hedge fund held 215,608 shares of the prepackaged software company at the end of 2018Q3, valued at $23.47 million, down from 269,112 at the end of the previous reported quarter. Glynn Capital Management Llc who had been investing in Veeva Systems Inc. for a number of months, seems to be less bullish one the $17.29B market cap company. The stock increased 0.25% or $0.3 during the last trading session, reaching $118.97. About 1.05M shares traded. Veeva Systems Inc. (NYSE:VEEV) has risen 62.15% since February 14, 2018 and is uptrending. It has outperformed by 62.15% the S&P500. Some Historical VEEV News: 24/05/2018 – Veeva Systems 1Q EPS 29c; 29/03/2018 – Nuvolo Names Veeva Systems Executive Dan Goldsmith to Board of Directors; 08/05/2018 – Yale University Discloses Positions in Pure Storage, Veeva — Barron’s Blog; 30/05/2018 – New Veeva Vault Training Provides Life Sciences a Modern Cloud Application for Effective Role-based Training; 24/05/2018 – VEEVA SYSTEMS INC VEEV.N SEES FY 2019 NON-GAAP SHR $1.36 TO $1.38; 17/04/2018 – Debiopharm International SA Strengthens Compliance and Clinical Trial Oversight with Veeva Vault eTMF; 27/03/2018 – Leading CROs Form New Industry Standards Group to Improve Collaboration With Sponsors; 24/05/2018 – Veeva Systems 1Q Rev $195.5M; 24/05/2018 – VEEVA SYSTEMS INC VEEV.N FY2019 SHR VIEW $1.32, REV VIEW $818.8 MLN — THOMSON REUTERS l/B/E/S; 24/05/2018 – Veeva Systems 1Q Adj EPS 33c

Wms Partners Llc increased its stake in Pfizer Inc (PFE) by 125.28% based on its latest 2018Q3 regulatory filing with the SEC. Wms Partners Llc bought 31,321 shares as the company’s stock rose 5.56% while stock markets declined. The hedge fund held 56,321 shares of the health care company at the end of 2018Q3, valued at $2.48 million, up from 25,000 at the end of the previous reported quarter. Wms Partners Llc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $241.05 billion market cap company. The stock decreased 0.41% or $0.17 during the last trading session, reaching $41.7. About 23.49M shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 14, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 01/05/2018 – Health Care Down After Merck, Pfizer Earnings — Health Care Roundup; 19/04/2018 – PFIZER, OTHER LARGE DRUG COS COULD ALSO LOOK AT SHIRE BID: BTIG; 29/03/2018 – Whoa, $ALNY -7% And from the PM bureau, @BrittanyMeiling has this: Watch out Alnylam/Ionis: Pfizer’s positive PhIII tafamidis data makes drug a new rival; 22/03/2018 – GSK advances in Pfizer consumer health auction as Reckitt quits; 10/04/2018 – Pfizer’s Xeljanz Barrels into Psoriatic Arthritis, Leaving Lilly’s Recently Launched Taltz in its Wake, According to a Recently; 28/03/2018 – New top 10!~ Elephants can’t jump? IDEA’s Mike Rea says some Big Pharma players are crushing old beliefs @ideapharma $AZN $PFE $NVS; 10/04/2018 – PFIZER – INDEPENDENT COMMITTEE FOR PHASE 3 ATLAS TRIAL OF INLYTA RECOMMENDED STOPPING TRIAL AT A PLANNED INTERIM ANALYSIS DUE TO FUTILITY; 19/03/2018 – PFIZER INC -; 07/05/2018 – PFIZER INDIA QTR NET 1.05B RUPEES; EST. 854M RUPEES; 21/03/2018 – RECKITT BENCKISER ENDS PFIZER TALKS ON CONSUMER HEALTHCARE UNIT

Glynn Capital Management Llc, which manages about $659.77 million and $497.07 million US Long portfolio, upped its stake in Halliburton Co. (NYSE:HAL) by 15,313 shares to 35,313 shares, valued at $1.43M in 2018Q3, according to the filing.

Investors sentiment decreased to 1.48 in Q3 2018. Its down 0.31, from 1.79 in 2018Q2. It fall, as 20 investors sold VEEV shares while 116 reduced holdings. 75 funds opened positions while 126 raised stakes. 104.55 million shares or 0.67% more from 103.85 million shares in 2018Q2 were reported. Bancorporation Of America De invested in 0.02% or 1.22 million shares. Proshare Advsrs Limited Liability Company owns 7,497 shares or 0.01% of their US portfolio. Malaga Cove Capital Ltd Liability Company reported 0.3% stake. Jag Capital Mngmt Lc invested 3.39% of its portfolio in Veeva Systems Inc. (NYSE:VEEV). Baldwin Brothers Ma holds 0% in Veeva Systems Inc. (NYSE:VEEV) or 300 shares. Sheets Smith Wealth Management stated it has 0.1% in Veeva Systems Inc. (NYSE:VEEV). 3,377 are held by Reliance Com Of Delaware. Strategic Advsrs Limited Company holds 5,912 shares. State Of Wisconsin Board stated it has 147,641 shares. Hbk Invests LP reported 115,309 shares or 0.13% of all its holdings. Qs Investors Ltd Co has 13,181 shares for 0.01% of their portfolio. Scout Invests owns 0.21% invested in Veeva Systems Inc. (NYSE:VEEV) for 91,378 shares. Westpac Banking Corporation has 0% invested in Veeva Systems Inc. (NYSE:VEEV). Ameriprise Fincl has invested 0.03% in Veeva Systems Inc. (NYSE:VEEV). State Of Alaska Department Of Revenue reported 14,707 shares.

Analysts await Veeva Systems Inc. (NYSE:VEEV) to report earnings on February, 26. They expect $0.31 earnings per share, up 82.35% or $0.14 from last year’s $0.17 per share. VEEV’s profit will be $45.04M for 95.94 P/E if the $0.31 EPS becomes a reality. After $0.35 actual earnings per share reported by Veeva Systems Inc. for the previous quarter, Wall Street now forecasts -11.43% negative EPS growth.

Among 19 analysts covering Veeva Systems (NYSE:VEEV), 11 have Buy rating, 0 Sell and 8 Hold. Therefore 58% are positive. Veeva Systems had 75 analyst reports since August 28, 2015 according to SRatingsIntel. On Wednesday, November 23 the stock rating was maintained by Canaccord Genuity with “Buy”. Needham maintained the shares of VEEV in report on Wednesday, March 1 with “Buy” rating. KeyBanc Capital Markets maintained the shares of VEEV in report on Sunday, November 12 with “Buy” rating. The firm earned “Buy” rating on Friday, May 25 by Canaccord Genuity. The rating was maintained by Deutsche Bank on Wednesday, November 25 with “Hold”. The stock of Veeva Systems Inc. (NYSE:VEEV) has “Overweight” rating given on Thursday, March 1 by Morgan Stanley. Morgan Stanley maintained the shares of VEEV in report on Friday, May 25 with “Overweight” rating. The rating was initiated by Goldman Sachs with “Neutral” on Tuesday, October 4. The stock of Veeva Systems Inc. (NYSE:VEEV) has “Hold” rating given on Tuesday, December 5 by Raymond James. Stifel Nicolaus maintained it with “Buy” rating and $43 target in Wednesday, August 31 report.

Since August 16, 2018, it had 0 insider buys, and 33 sales for $31.63 million activity. On Wednesday, September 12 Zuppas Eleni Nitsa sold $395,048 worth of Veeva Systems Inc. (NYSE:VEEV) or 3,800 shares. Cabral Timothy S also sold $2.31 million worth of Veeva Systems Inc. (NYSE:VEEV) shares. Wallach Matthew J also sold $1.00M worth of Veeva Systems Inc. (NYSE:VEEV) on Thursday, December 20. The insider BARABE TIMOTHY C sold 727 shares worth $76,335. $57,454 worth of Veeva Systems Inc. (NYSE:VEEV) shares were sold by MATEO ALAN. $136,750 worth of stock was sold by Lequient Frederic on Saturday, September 1.

More notable recent Veeva Systems Inc. (NYSE:VEEV) news were published by: Fool.com which released: “3 Pick-and-Shovel Biotechnology Stocks – The Motley Fool” on January 25, 2019, also Businesswire.com with their article: “Align Clinical CRO Publishes New Operational Data Exchange Standard for Life Sciences Industry Input – Business Wire” published on January 15, 2019, Businesswire.com published: “More than 150 Companies Adopt Veeva Vault RIM Applications to Streamline Regulatory Processes – Business Wire” on February 12, 2019. More interesting news about Veeva Systems Inc. (NYSE:VEEV) were released by: Seekingalpha.com and their article: “Veeva Continues To Soar To New Highs – Seeking Alpha” published on August 29, 2018 as well as Seekingalpha.com‘s news article titled: “Veeva Continues To Soar – Seeking Alpha” with publication date: December 20, 2018.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, September 13 with “Buy”. The rating was maintained by BMO Capital Markets on Wednesday, May 2 with “Outperform”. The stock has “Buy” rating by Jefferies on Thursday, April 7. The rating was maintained by Jefferies on Wednesday, August 16 with “Hold”. The company was reinitiated on Thursday, April 7 by JP Morgan. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by Morgan Stanley on Friday, October 2. The rating was initiated by Barclays Capital with “Equal-Weight” on Tuesday, December 1. The firm has “Buy” rating by Jefferies given on Tuesday, June 14. As per Thursday, January 31, the company rating was upgraded by Credit Suisse. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Friday, August 28. Piper Jaffray has “Overweight” rating and $48 target.

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Virginia-based Burney has invested 0.42% in Pfizer Inc. (NYSE:PFE). Cibc Bancorporation Usa invested in 0.36% or 60,371 shares. Polar Ltd Liability Partnership reported 1.02% in Pfizer Inc. (NYSE:PFE). 933,851 were reported by Cambridge Inv Rech. Cooke Bieler LP holds 0% or 5,600 shares in its portfolio. Centurylink Inv Management Communication has 1.32% invested in Pfizer Inc. (NYSE:PFE) for 83,831 shares. Of Virginia Va accumulated 0.38% or 64,000 shares. Zeke Advisors Limited Liability Corporation holds 0.68% or 187,642 shares in its portfolio. Cetera Limited owns 113,365 shares. The California-based Palo Cap has invested 0.57% in Pfizer Inc. (NYSE:PFE). Horrell Management Incorporated accumulated 0% or 159 shares. Hudock Cap Gp Lc holds 1.41% of its portfolio in Pfizer Inc. (NYSE:PFE) for 82,626 shares. Riverhead Capital Management Limited Co reported 0.81% in Pfizer Inc. (NYSE:PFE). Northwestern Mutual Wealth Mngmt stated it has 0.11% of its portfolio in Pfizer Inc. (NYSE:PFE). Baldwin Invest Mngmt Ltd accumulated 7,428 shares or 0.09% of the stock.

Since January 30, 2019, it had 0 insider buys, and 1 insider sale for $1.81 million activity.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” on January 30, 2019, also Seekingalpha.com with their article: “Pfizer Biopharmaceuticals Group’s Late-Stage Pipeline Looks Well Positioned – Seeking Alpha” published on February 06, 2019, Streetinsider.com published: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” on February 11, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Is Pfizer a Buy? – Motley Fool” published on January 16, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer recalls contaminated high blood pressure drug in Japan – Seeking Alpha” with publication date: February 08, 2019.

Wms Partners Llc, which manages about $2.55B and $890.61M US Long portfolio, decreased its stake in Vanguard Index Fds (VO) by 5,314 shares to 59,201 shares, valued at $9.72M in 2018Q3, according to the filing. It also reduced its holding in Vanguard Index Fds (VTI) by 5,487 shares in the quarter, leaving it with 756,484 shares, and cut its stake in Weingarten Rlty Invs (NYSE:WRI).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart